Potential tumor-suppressing gene identified in pancreatic cancer

Low levels of CTDNEP1 may drive early and deadly pancreatic tumors, highlighting its role as a tumor suppressor

2026-01-15

(Press-News.org)

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the pancreatic duct. Accounting for more than 90% of all pancreatic cancers, PDAC is extremely difficult to treat and has a very high mortality rate. According to the Global Cancer Observatory 2022 report, pancreatic cancer is the sixth most common cancer in Japan, with over 47,000 new cases and more than 40,000 deaths, making it the fourth leading cause of cancer-related mortality in the country.

In search of potential treatments, Ms. Mayuka Nii, a second-year doctoral student, and Professor Tadayoshi Hayata from the Faculty of Pharmaceutical Sciences at Tokyo University of Science, Japan, have turned their attention to the gene CTD nuclear membrane phosphatase 1 (CTDNEP1). This gene encodes a phosphatase involved in several cellular pathways and is known to be involved in medulloblastoma, a pediatric brain tumor. Previously, the researchers found that CTDNEP1 plays a suppressive role in osteoclast cell differentiation, which are cells involved in the breakdown and removal of old or damaged bone tissue. Now, with the results of their study, researchers believe that this gene may also play a protective role in pancreatic cancer and could contribute to its early detection. The study was online published in Volume 23, Issue 1 of the journal Cancer Genomics & Proteomics on January 01, 2026.

“PDAC is one of the most difficult cancers to treat and has a very high mortality rate. To find new treatments, it is important to identify genes involved in cancer progression. Our research points to CTDNEP1 as a possible tumor-suppressing gene that could help slow the cancer,” says Prof. Hayata.

To explore this, the researchers analyzed data from The Cancer Genome Atlas (TCGA) and the Pan-Cancer Atlas, which include genetic and clinical information from 184 patients with PDAC. They also used TIMER2.0 (Tumor IMmube Estimation Resource) and UALCAN (the University of ALabama at Birmingham CANcer data analysis Portal), two web resources for studying cancer-related genes and immune cell infiltration. Using these sources, the team examined CTDNEP1's relationship with patient survival, its biological functions, and its interaction with the tumor’s immune environment.

Their findings reveal that CTDNEP1 plays an important role in pancreatic cancer. CTDNEP1 levels were significantly lower in PDAC tissue compared to healthy tissue, especially in the early stages of the disease. When CTDNEP1 was low, tumors were more likely to carry harmful mutations in key cancer-related genes such as KRAS and TP53. Patients with low CTDNEP1 expression had significantly poorer survival rates, particularly those diagnosed with stage II cancer.

CTDNEP1 was also found to influence the tumor microenvironment. They found that low CTDNEP1 expression creates an environment that helps tumors evade the immune system. Low expression was associated with chronic inflammation, which can damage surrounding tissues and promote tumor growth. In contrast, tumors with high CTDNEP1 expression showed stronger metabolic and mitochondrial activity and had higher infiltration of immune cells, suggesting a more active and less suppressed immune environment.

“These results suggest that CTDNEP1 low expression occurs early in pancreatic cancer and may play a role in disease progression and malignancy,” explains Prof. Hayata. This means CTDNEP1 could help in the early detection of pancreatic cancer, serve as a prognostic indicator for predicting disease severity, and potentially act as a therapeutic target, where modulating its activity might help slow or stop tumor growth. “Personally, I have several acquaintances who died very young from pancreatic cancer. Hence, I undertook this research and it is my mission and personal desire as a researcher to translate this research into medical care,” shares Prof. Hayata.

Building on these discoveries, the research team is now conducting in vitro and in vivo investigations to understand how CTDNEP1 affects pancreatic cancer cell proliferation, metastasis, and immune interactions. By identifying the regulatory mechanisms that control CTDNEP1 expression, the researchers aim to uncover new therapeutic targets. Although the clinical significance of CTDNEP1 is still emerging, its potential role in early detection and disease modulation makes it a compelling candidate for future pancreatic cancer treatments.

While these findings are data-driven, they offer a promising starting point, which may ultimately lead to new and effective strategies against this disease.

***

Reference
DOI: 10.21873/cgp.20567

About The Tokyo University of Science
Tokyo University of Science (TUS) is a well-known and respected university, and the largest science-specialized private research university in Japan, with four campuses in central Tokyo and its suburbs and in Hokkaido. Established in 1881, the university has continually contributed to Japan's development in science through inculcating the love for science in researchers, technicians, and educators.

With a mission of “Creating science and technology for the harmonious development of nature, human beings, and society," TUS has undertaken a wide range of research from basic to applied science. TUS has embraced a multidisciplinary approach to research and undertaken intensive study in some of today's most vital fields. TUS is a meritocracy where the best in science is recognized and nurtured. It is the only private university in Japan that has produced a Nobel Prize winner and the only private university in Asia to produce Nobel Prize winners within the natural sciences field.

Website: https://www.tus.ac.jp/en/mediarelations/

About Professor Tadayoshi Hayata from Tokyo University of Science
Dr. Tadayoshi Hayata became an Associate Professor and Principal Investigator at the Department of Molecular Pharmacology, Faculty of Pharmaceutical Science at the Tokyo University of Science in 2018. In 2023, he was promoted to Full Professor. His laboratory focuses on bone metabolism, cellular differentiation, molecular pharmacology, and similar fields to understand the nature of bone and joint diseases and find therapeutic targets. Prof. Hayata is affiliated with several Japanese Societies and the American Society for Bone and Mineral Research. He has published over 90 original articles and given over 70 presentations at academic conferences. In addition, his research on osteoporosis has made it to Japanese newspapers several times.
Laboratory website
Official TUS website

END

ELSE PRESS RELEASES FROM THIS DATE:

Winners of the 2026 Hill Prizes announced

2026-01-15

January 15, 2026 – Dallas – TAMEST (Texas Academy of Medicine, Engineering, Science and Technology) and Lyda Hill Philanthropies today announced the recipients of the 2026 Hill Prizes. The prizes, funded by Lyda Hill Philanthropies, propel high-risk, high-reward ideas and innovations that demonstrate significant potential for real-world impact and can lead to new, paradigm-shifting paths in research. The prizes are given in seven categories: artificial intelligence, biological sciences, engineering, medicine, physical sciences, public health and technology. They recognize and advance top Texas innovators, providing seed funding to advance groundbreaking science and highlight ...

Autonomous AI agents developed to detect early signs of cognitive decline

2026-01-15

A team of Mass General Brigham researchers has developed one of the first fully autonomous artificial intelligence (AI) systems capable of screening for cognitive impairment using routine clinical documentation. The system, which requires no human intervention or prompting after deployment, achieved 98% specificity in real-world validation testing. Results are published in npj Digital Medicine. Alongside the publication, the team is releasing Pythia, an open-source tool that enables any healthcare system or research institution to deploy autonomous prompt optimization for their own AI screening applications. "We didn't build a single AI model — ...

Study finds ocean impacts nearly double economic cost of climate change

2026-01-15

For the first time, a study from researchers at Scripps Institution of Oceanography at the University of California San Diego integrates climate-related damages to the ocean into the social cost of carbon— a measure of economic harm caused by greenhouse gas emissions. When ocean damage from climate change, dubbed the “blue” social cost of carbon, is calculated, the study finds that the global cost of carbon dioxide emissions to society nearly doubles. Until now, the ocean was largely overlooked in the standard accounting of the social cost ...

Increased deciduous tree dominance reduces wildfire carbon losses in boreal forests

2026-01-15

As climate change drives more frequent and severe wildfires across boreal forests in Alaska and northwestern Canada, scientists are asking a critical question: Will these ecosystems continue to store carbon or become a growing source of carbon emissions? New research published this week shows that when forests shift from coniferous—consisting mostly of pines, spruces and larches—to deciduous—consisting mostly of birches and aspens—they could release substantially less carbon when they burn. The National Science Foundation-funded study, led by researchers from the Center for Ecosystem Science and Society (ECOSS) at Northern Arizona University and published in ...

Researchers discover how a respiratory bacterium obtains essential lipids from the human body and targets fat-rich tissues

2026-01-15

Barcelona, January 15, 2026. A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholesterol and other essential lipids directly from the human body. The discovery, published in Nature Communications, was co-led by Dr. Noemí Rotllan, from the Sant Pau Research Institute (IR Sant Pau) and the Center for Biomedical Research in Diabetes and Associated Metabolic Disorders (CIBERDEM); Dr. Marina Marcos, from the Autonomous University of Barcelona (UAB); and Dr. David Vizarraga, from the Institute of Molecular Biology ...

Locust swarms destroy crops. Scientists found a way to stop that

2026-01-15

“They’re very destructive when there's a lot of them, but one-on-one, what's not to love?” says Arianne Cease. She’s talking about locusts. As the director of Arizona State University’s Global Locust Initiative, Cease has a healthy admiration for these insects, even as she studies ways to manage locust swarms and prevent the destruction they cause. Locust swarms, which may conjure images of biblical plagues and ancient famines, remain a serious problem worldwide. They can destroy crops across entire regions, ruin people’s livelihoods, ...

More resources and collaboration needed to support prevention and treatment of obesity

2026-01-15

Statement Highlights: More than one-third of adults and children in the U.S. are living with obesity. Obesity rates are highest among non-Hispanic Black children and adults, low-income families, people living in rural areas and adults with a high school education or less. The latest research indicates that barriers to maintaining a healthy weight or participating in weight management programs include: limited access to healthy foods, lack of time to prepare meals and engage in regular physical activity, ...

Two types of underconfidence linked to anxiety and gender

2026-01-15

Women and people with anxiety are both prone to low confidence in their own abilities, but a new study by University College London (UCL) researchers has found that the two groups are prone to two distinct types of underconfidence. When they took more time to reflect on their answers in a simple experimental task, people with anxiety grew less confident in their answers, while women who were underconfident gained confidence. Lead author, Dr Sucharit Katyal, who completed the work as a postdoctoral researcher at the Max Planck UCL Centre ...

Insects are victims too: Global study shows impacts of invasive alien species on populations

2026-01-15

Insects are often seen as invaders due to high-profile species like the yellow-legged (Asian) hornet, the harlequin ladybird and fire ant. but new research reveals insects are also major victims of invasive alien species – exacerbating population declines and reducing their ability to provide vital services for biodiversity and people from pollination to pest control. The first global analysis of its kind, led by the UK Centre for Ecology & Hydrology (UKCEH), revealed that invasive alien species reduce abundance of terrestrial insects* by 31% on average and reduce species richness by 21%. Invasive animals outcompete or eat insects while invasive vegetation replaces ...

Pioneering natural, degradable polymer capsules

2026-01-15

Polymer capsules can store functional substances such as drugs and fragrances, making them widely used in functional cosmetics and daily necessities. However, conventional capsules use non-degradable polymers and are difficult to decompose in natural environments. They are identified as a contributing factor to the marine microplastics problem, and concerns have been raised about their impact on the ecosystem and human health. In search of an alternative, a research group led by Associate Professor Yukiya Kitayama at ...

Potential tumor-suppressing gene identified in pancreatic cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: